Pharmacology · Antiepileptics and CNS Drugs (Antipsychotics, Antidepressants, Sedatives)

Valproate inhibits which enzyme involved in GABA metabolism, thereby contributing to its anticonvulsant action?

  • A GABA transaminase (GABA-T), increasing synaptic GABA availability
  • B Glutamic acid decarboxylase, reducing glutamate conversion
  • C Monoamine oxidase, preventing GABA degradation
  • D Succinic semialdehyde dehydrogenase, causing GABA accumulation
Correct answer: A. GABA transaminase (GABA-T), increasing synaptic GABA availability

Explanation

Valproate's GABA-enhancing mechanism includes inhibition of GABA transaminase (GABA-T), the pyridoxal phosphate-dependent enzyme that converts GABA to succinic semialdehyde, thereby reducing GABA catabolism. Valproate also inhibits succinic semialdehyde dehydrogenase (option D describes this as GABA accumulation but GABA-T is the primary step). Additionally, valproate enhances GABA synthesis by upregulating glutamic acid decarboxylase. Its broad-spectrum efficacy also involves sodium channel blockade and inhibition of T-type calcium channels in the thalamus.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Antiepileptics and CNS Drugs (Antipsychotics, Antidepressants, Sedatives) MCQs

See all Antiepileptics and CNS Drugs (Antipsychotics, Antidepressants, Sedatives) MCQs →